Loading stock data…
OSG
$5.57+0.20 (+3.72%)
After Hours$5.57+0.00 (+0.00%)· Last close May 11
Octave Specialty Group, Inc., an insurance holding company, primarily engages in the specialty property and casualty insurance business in the United States and the United Kingdom.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Octave Specialty Group, Inc. in the Financial Services sector is trading at $5.57. The stock is currently 46% below its 52-week high of $10.38, remaining 22.3% below its 200-day moving average. Technical signals show neutral RSI of 63 and bullish MACD crossover, explaining why OSG maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 63) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JPMBACGS
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$5.57
Potential Upside
5%
Whystock Fair Value$5.85
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus3 analysts
Mean target$15.33+175.3%
Range$12.00 – $19.00
Fundamentals
Octave Specialty Group, Inc., an insurance holding company, primarily engages in the specialty property and casualty insurance business in the United States and the United Kingdom. It operates in two segments, Specialty Property and Casualty Insuranc...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$206.61M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.88
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-36.56%
Volume
Today's trading volume
568,343
Recent News
This Fund Disclosed Selling $18 Million in Alphatec Last Quarter. The Stock Just Tanked 20% After Earnings
This medical technology firm provides spinal surgery solutions to U.S. hospitals and surgical centers through proprietary devices.
Western Standard Sells Entire Select Medical Position Ahead of $3.9 Billion Buyout
Select Medical Holdings delivers rehabilitation and occupational health services through a nationwide network of hospitals and clinics.
Corebridge Financial (CRBG) Misses Q1 Earnings and Revenue Estimates
Corebridge (CRBG) delivered earnings and revenue surprises of -1.43% and -14.18%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Markel Group (MKL) Q1 Earnings and Revenues Lag Estimates
Markel Group (MKL) delivered earnings and revenue surprises of -18.08% and -4.04%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Octave Specialty Group Insiders Placed Bullish Bets Worth US$1.34m
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...